Research highlighted in this survey

The insights introduced throughout the survey are drawn from studies in mental well-being, behavior change, and psychedelic experiences. Here is a list of the data and sources shared through the survey.

“...about 33% of cancer survivors experience depression and 31% experience anxiety during recovery.”
Zhao J, et al. Prevalence of anxiety and depression among cancer survivors: a meta-analysis of observational studies. BMC Psychiatry. 2025.

“Over half of trauma survivors (50–70%) report at least one area of personal growth…”
Tedeschi RG, Calhoun LG. The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. Journal of Traumatic Stress. 1996.

“The quality of the relationship with a therapist is one of the strongest predictors of therapy’s effectiveness.”
Horvath AO, Symonds BD. Relation between working alliance and outcome in psychotherapy: a meta-analysis. Journal of Counseling Psychology. 1991.

“When therapists and clients agree on clear goals and a shared plan, outcomes improve.”
Tryon GS, Winograd G. Goal consensus and collaboration. In: Norcross JC (ed.), Psychotherapy Relationships That Work: Therapist Contributions and Responsiveness to Patients. Oxford University Press. 2011.

“Affordability and logistics are among the top reasons people stop therapy early.” Barrett MS, Chua WJ, Crits-Christoph P, Gibbons MB, Casiano D, Thompson D. Early withdrawal from mental health treatment: implications for psychotherapy practice. Psychotherapy (Chic). 2008

“When the approach doesn’t fit the person’s needs, it’s less likely to be effective.”
Cuijpers P, et al. Tailoring psychological interventions to patient characteristics: a meta-analysis of depression treatments. Psychological Bulletin. 2016.
 

“Practicing skills outside of sessions is strongly associated with long-term improvement.”
Kazantzis N, et al. Homework assignments in cognitive behavioral therapy: a meta-analysis. Clinical Psychology: Science and Practice. 2010.

“When financial barriers are reduced, people are more likely to engage regularly in therapy.”
Wang PS, et al. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry. 2005.

“Barriers like cost, time, and uncertainty about effectiveness are among the most common reasons people don’t engage in therapy.”
Andrade LH, et al. Barriers to mental health treatment: results from the WHO World Mental Health Surveys. Psychological Medicine. 2014.

“Research shows many people describe psychedelic experiences as meaningful or expansive when used in supportive settings.”
Griffiths RR, et al. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology. 2006.
 

“Even positive journeys can bring emotional highs and lows that take time to integrate.”
Carbonaro TM, et al. Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences. Journal of Psychopharmacology. 2016.

“Challenging experiences can sometimes lead to insight or growth with the right support.”
Davis AK, et al. Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2020.

“Most felt better within weeks, and about half still showed no depression two years later.” Agrawal M, et al. Psilocybin therapy in cancer-related depression.JAMA Oncology. 2023.

‍